Radiotherapy Reprograms Immune Response in Rare Skin Cancer
A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell lymphoma tumors, revealing new molecular signatures associated with long-term…
Read the full articleYou might also wanna read
Immunotherapy Shifts Treatment Paradigm for Hard-to-Cure Small Cell Lung Cancer
Immunotherapy is transforming treatment for small cell lung cancer, a hard-to-cure disease, cutting recurrence and death risk by 30% and ext
A revolutionary cancer treatment could transform autoimmune disease
Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body
Gut microbiome composition predicts melanoma recurrence risk in patients on immunotherapy, large trial finds
In 674 high-risk melanoma patients across five regions, the gut microbiome differs by region but remains stable during ICB treatment, and re
T cell-myeloid reprogramming overcomes immune resistance in colorectal cancer models
Mestrallet et al. show that T cell-myeloid interactions determine response to PD-1 blockade in colorectal cancer. Targeting TREM2 macrophage
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fib
Científicos financiados por los Institutos Nacionales de la Salud descubren pistas sobre las lesiones precancerosas y la biología tumoral
En nuevos estudios publicados por la Red del Atlas de Tumores Humanos (HTAN) del Instituto Nacional del Cáncer (NCI), se explora la función
Comments
Sign in to join the conversation.
No comments yet. Be the first.